The global prescribed medications for acute treatment of migraine Market size was valued at USD 2,587.9 million in 2021 and is poised to grow at a significant CAGR of 13.7% during the forecast period 2022-28. The market for prescribed medications for acute treatment of migraine is expected to offer lucrative opportunities for the market players due to the launch of novel molecules in the U.S....
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian